Zofran

Zofran

Zofran, also known as ondansetron, is an anti-nausea medication designed to help chemotherapy patients. However, it began to be prescribed to cope with vomiting in a variety of situations it wasn’t designed for, including preventing morning sickness in pregnant women. Unfortunately, this medication was linked to an increased risk of birth defects. The company delayed in warning consumers about birth defect risks, and as a result many families were harmed. If you took Zofran while pregnant and had a baby with a birth defect, the attorneys at Benner Law would like to talk to you about your case.

Even though Zofran hadn’t been tested for pregnant women, companies promoted it as an effective morning sickness treatment. By 2013, over 1 million pregnant women were using Zofran. Now, a number of medical journals have published evidence linking Zofran to a variety of birth defects, such as heart defects, cleft palate, club foot, musculoskeletal defects, and fetal growth restriction. Even as companies became aware of these problems, they failed to promptly publish warnings about the potential harm. As a result of their hesitation, countless infants have been born with serious life-threatening medical conditions.

There’s nothing as difficult for a family as coping with a birth defect. If a company’s negligence is responsible, you and your family are entitled to damages. You deserve to be compensated for the medical expenses, lost wages, and emotional distress of your situation. At Benner Law, our tort attorneys have the experience and knowledge necessary to take on large pharmaceutical companies and get results.

FREE STRATEGY SESSION